Company
United StatesPublic company, NASDAQ: GILDGilead Sciences Inc (NASDAQ: GILD), San Dimas, CA – FDA Inspections
Inspection records and compliance data for Gilead Sciences Inc in San Dimas, California. 7 FDA inspections on record (1 OAI), last inspected April 26, 2018. Publicly traded as NASDAQ: GILD.
Company Profile
This profile covers Gilead Sciences Inc based in San Dimas, California, United States.
FDA Inspection History
- FDA inspections
- 7
- OAI
- 1
- VAI
- 1
- NAI
- 5
- Form 483s
- 0
- Warning letters
- 0
First inspected February 12, 2010. Last inspected April 26, 2018.
Most cited issue areas
- Acceptance criteria for sampling & testing1 inspection
- Air Supply1 inspection
- Aseptic Processing Area1 inspection
FDA inspections (7)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| April 26, 2018 | NAI | Human Drugs · Drug Quality Assurance | 1057465 |
| January 19, 2016 | NAI | Human Drugs · Drug Quality Assurance | 986126 |
| May 16, 2014 | VAI | Human Drugs · Drug Quality Assurance | 880678 |
| August 7, 2013 | NAI | Human Drugs · Drug Quality Assurance | 846107 |
| August 3, 2012 | NAI | Human Drugs · Drug Quality Assurance | 793344 |
| December 7, 2010 | NAI | Human Drugs · Drug Quality Assurance | 701937 |
| February 12, 2010 | OAI | Human Drugs · Drug Quality Assurance | 645091 |
FDA documents
Form 483s (1)
People (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Gilead Sciences Inc
Stock ticker
GILD
Exchange
NASDAQ
Share price
$167.95
Market cap
$208.3B
Price as of
November 13, 2026
FEI Number
2082946
Address
650 Cliffside Dr, San Dimas, California 91773, United States
Country
United States
ID: 25d591ee-1217-4ca3-9134-ed69477f677f